With the availability of the latest Pfizer (COMIRNATY®) Omicron XBB.1.5 vaccine, indicated for 12 years and over, there may be potential for selection or administration
Disclaimer: This article was published in 2022 and reflects the information available at that time. The recent availability of the Moderna Spikevax Bivalent Booster
Disclaimer: This article was published in 2022 and reflects the information available at that time. The recent surge in demand for influenza vaccines has
Disclaimer: This article was published in 2022 and reflects the information available at that time. As winter approaches, pharmacies will be very busy providing
Disclaimer: This article was published in 2022 and reflects the information available at that time. The ATAGI approval of Moderna Spikevax for the primary
Disclaimer: This article was published in 2021 and reflects the information available at that time. The approval of the Pfizer Comirnaty Orange Cap (5-11 years) COVID-19 vaccine to be administered
Disclaimer: This article was published in 2021 and reflects the information available at that time. Vaccinating pharmacists take note… The Moderna Spikevax vaccine has
Disclaimer: This article was published in 2021 and reflects the information available at that time. The PDL Professional Officers have noted a recent reduction
Disclaimer: This article was published in 2021 and reflects the information available at that time. PDL recognises the extraordinary efforts that pharmacists have made
Disclaimer: This article was published in 2021 and reflects the information available at that time. The PDL Professional Officers continue to assist pharmacists with
Pharmaceutical Defence Limited (PDL) acknowledges the Traditional Owners of Country throughout Australia and their continuing connection to land, waters and community. We pay our respects to the people, the cultures and the Elders past and present.